Projects per year
Personal profile
Biography
Dr Ho Chi Lui is currently Professor with School of Pharmacy, Monash University Malaysia. He obtained his B. Pharm. (Hons) and Ph.D. from the University of Queensland. After graduation, he did his postdoctoral study at the respective Upjohn Center for Clinical Pharmacology, University of Michigan (Ann Arbor) and Queensland Institute for Medical Research. He also did an attachment at the National Institute for Aging, National Institutes of Health (Baltimore). In 2011, Dr Ho was awarded the outstanding medical graduate drug technology mentor award by the American Association of Pharmaceutical Scientists in Washington DC; and the outstanding scientist award by the Faculty of Science, National University of Singapore. Dr Ho is the honorary professor of Xi’an Jiaotong University. Dr Ho was one of the thrust leads in the Centre for Additive Manufacturing (AM@NUS), contributing to 3D printing for pharmaceutical application. Dr Ho is a licensed pharmacist in both Singapore and Australia.
Biography
Research Interests
Dr Ho’s current research interests are on pharmacokinetics and biopharmaceutics for CNS diseases, especially on drug resistant epilepsy, and Alzheimer’s disease.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Research area keywords
- Pharmacokinetics
- Drug Delivery Systems
- Pharmaceutical Analysis
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 1 Active
-
Deciphering psoriatic complexity by unravelling novel microbial dynamics across severity spectra and their unexplored impacts on the secretome and autoimmune responses in 3D skin microenvironment
Khong, N. (Primary Chief Investigator (PCI)), Lee, R. (Chief Investigator (CI)), Ho, P. C. L. (Chief Investigator (CI)), Dolzhenko, A. V. (Chief Investigator (CI)), Lim, W. M. (Chief Investigator (CI)) & Kruasuwan, W. (Chief Investigator (CI))
1/08/24 → 31/07/27
Project: Research
-
Exploring metabolic biomarkers and pathways in pharmacoresistant epilepsy: A systematic review
Lim, Z. D., Abdullah, N. A. S., Lim, K. S., Ho, P. C. L., Arulsamy, A., Fong, S. L. & Yow, H. Y., Dec 2025, In: Epilepsy Research. 218, 16 p., 107656.Research output: Contribution to journal › Review Article › Research › peer-review
-
GC-MS uncovers unique metabolic markers of drug-resistant epilepsy in capillary but not venous dried blood spots
Kong, S. T., Lim, S. H., Ching, J. & Ho, P. C. L., 15 Jan 2025, In: Journal of Pharmaceutical and Biomedical Analysis. 253, 10 p., 116561.Research output: Contribution to journal › Article › Research › peer-review
Open Access4 Citations (Scopus) -
Biological and Physiological Features of the Gastrointestinal Tract Relevant to Oral Drug Absorption
Ho, P. C. L., 2024, Oral Bioavailability and Drug Delivery: From Basics to Advanced Concepts and Applications. Hu, M. & Li, X. (eds.). Hoboken, New Jersey USA: Wiley-Academy, p. 47-59 13 p.Research output: Chapter in Book/Report/Conference proceeding › Chapter (Book) › Research › peer-review
-
Conjugating uncoupler compounds with hydrophobic hydrocarbon chains to achieve adipose tissue selective drug accumulation
Ng, M. Y., Song, Z. J., Venkatesan, G., Rodriguez-Cuenca, S., West, J. A., Yang, S., Tan, C. H., Ho, P. C. L., Griffin, J. L., Vidal-Puig, A., Bassetto, M. & Hagen, T., Dec 2024, In: Scientific Reports. 14, 1, 17 p., 4932.Research output: Contribution to journal › Article › Research › peer-review
Open Access1 Citation (Scopus) -
Exploration of Nutraceutical Potentials of Isorhapontigenin, Oxyresveratrol and Pterostilbene: A Metabolomic Approach
Dai, Y., Wang, J., Yang, Y., Jin, H., Liu, F., Liu, H., Ho, P. C. & Lin, H. S., Oct 2024, In: International Journal of Molecular Sciences. 25, 20, 24 p., 11027.Research output: Contribution to journal › Article › Research › peer-review
Open Access5 Citations (Scopus)
-
1st International Conference in Pharmaceutics and Cosmetics (ICPCos), Bangkok, cohosted by Chulalongkorn University and Monash University Malaysia
Ho, P. C. L. (Organiser)
18 Nov 2024 → 19 Nov 2024Activity: Participating in or organising an event types › Contribution to conference
-
Quality of Beauty Quantified: A Full Skincare System Evaluation via BeautyQoL and Skin Analytics
Ho, P. C. L. (Contributor)
19 Nov 2024Activity: Community Talks, Presentations, Exhibitions and Events › Public lecture/debate/seminar